Rheumatoid Arthritis: New Targeted Treatments
Online CME Program
Stephen A. Paget, MD, FACP, FACR
Physician-in-Chief and Chairman
Division of Rheumatology
Hospital for Special Surgery
The Joseph P. Routh Professor of Medicine
Weill Medical College of Cornell University
New York, New York
Cornelia M. Weyand, MD, PhD
David C. Lowance Professor of Medicine
Co-Director of the Lowance Center
Emory University School of Medicine
Atlanta, Georgia
Josef S. Smolen, MD
Professor of Rheumatology
2nd Department of Medicine
University of Vienna
Vienna, Austria
Larry W. Moreland, MD
Anna Lois Waters Professor of Medicine
Associate Dean for Clinical Research
University of Alabama at Birmingham School of Medicine
Birmingham, Alabama
The Program
[View the Course Description]
-
Introduction (Video Presentation)
Stephen A. Paget, MD, FACP, FACR
-
Immunopathologic Aspects of RA: Who is the Conductor and Who Plays the Immunologic Instruments? (Video Presentation)
Cornelia M. Weyand, MD, PhD
-
What Is the Place of Recently Approved B-Cell-Targeted and T-Cell-Targeted Therapies in the Treatment of RA? Lessons from Global Clinical Trials (Video Presentation)
Josef S. Smolen, MD
-
Disease Modifiers: Making the Right Therapeutic Choices for Our Patients (Video Presentation)
Larry W. Moreland, MD
-
Guiding Optimal Therapy With the Use of Disease Activity and Functional Instruments: Lessons From the Clinical Laboratory (Video Presentation)
Stephen A. Paget, MD, FACP, FACR
-
Panel Discussion and Closing Remarks (Video)
CME Credit
Please register to obtain CME credit for this program.
posted 6/1/2007, last updated and reviewed 8/1/2007
